Sio Gene Therapies’ Exit From Oxford Biomedica Parkinson’s Collaboration Leaves Hole In Commercial Prospects

Firm Loses CEO

Parkinson's disease, substantia nigra, Lewy bodies.
Parkinson's Disease Represented The Biggest Market Opportunity For The Firm, One Expert Said. • Source: Alamy

More from Business

More from Scrip